Opportunity overview
Dried Blood Spot Testing for Blood Bourne Viruses
Awarded to
Amounts belong to published awards or contracts. Where several suppliers share one value, it is labelled as shared and is not a supplier-specific allocation.
- Published award value
- Value not stated
- Awarded
- Not supplied
- Contract signed
- 12 Aug 2026
- Award ID
- 077254-2026-RRE-01232-1
- Status
- active
- Location
- Sheffield, UKE32, S10 2JF, United Kingdom
Classification
- CPV85145000 — Services provided by medical laboratories
Lots
- Midlands Partnership University NHS Foundation Trust (MPFT) are awarding to a provider of Blood Borne Virus Testing (BBV) to support and work in partnership with their substance misuse service teams. The Trust is looking to procure a provider who is able to provide the services with testing kits, lab testing and electronic results reporting. The Inclusion Services within MPFT have a national footprint and as such a Provider would be required to deliver across national geographic areas as required. Presently Inclusion deliver Community Drug & Alcohol Services in the following areas: • Buckinghamshire – multiple sites • Hampshire – multiple sites • Isle of Wight • Telford • Staffordshire – multiple sites The above location list outlines current locations, should the trust acquire further locations across the UK, the provider shall endeavour to accommodate these additional locations. The provider of BBV Testing will be required to : • Ensure that there is a consistent and affordable provision of self testing kits available; • Ensure robust and secure information channels for the notification of results in a timely manner; • Provide ongoing support before, during and after the testing process; • Future proof the service to support future growth of work; • Ensure a high quality and robust analytical service; • Provide flexibility to meet changing service demands; • Provide coverage on a national geographic basis. The Trust require the following to be available to test through a *dry blood spot testing method: • HBSAg & HBcAb • HIV (1&2) • Hep C AB • HEP C PCR (to be automatically tested if Hep C Ab is positive) MPFT intend to award this contract to an existing provider following direct award process C. The approximate lifetime value of this contract is £336,839.19 for a 2 year term with an option to extend for up to 12 months. This contract will begin 1st September 2026 and the maximum expiry date will be 31st August 2029.Value not stated